This is an excellent question that highlights the difference between genetic potential and actual metabolic output.
Key distinctions:
Functional capacity in Tiny Health GHT (DNA-based):
- Measures genes present in the microbiome
- Indicates what can happen if conditions are right
- Remains relatively stable over short periods
- Independent of current substrate availability
Stool chemistry in Tiny Health PRO GHT (metabolite-based):
- Measures actual compounds in stool
- Reflects what is happening right now
- Varies with recent diet, transit time, and microbial activity
- Snapshot of current metabolic output
Why they may not correlate:
1. Substrate limitation:
- High butyrate gene capacity but low fiber intake → low actual butyrate
- Genes present but not expressed due to a lack of fermentable substrate
2. Gene expression variability:
- Genes present but not actively transcribed
- Environmental factors (pH, oxygen, bile acids) affect gene expression
- Transit time affects fermentation opportunity
3. Transit time effects:
- Rapid transit → less time for fermentation → lower SCFA despite gene capacity
- Slower transit → more fermentation → higher output
4. Absorption and utilization:
- SCFAs absorbed by colonocytes (especially butyrate)
- Stool levels may be low because SCFAs were utilized, not because production was low
5. Timing and sampling:
- Stool chemistry reflects 1-2 days of output
- Functional capacity reflects microbiome composition over weeks
Clinical approach:
- High capacity + high output: Optimal function
- High capacity + low output: Address substrates (increase fiber), improve transit time
- Low capacity + low output: Rebuild beneficial taxa, then optimize substrates
- Low capacity + high output: Consider non-microbial influences
Use both measures complementarily: functional capacity guides potential for improvement, while stool chemistry confirms actual therapeutic response.
Comments
0 comments
Article is closed for comments.